Takasago (Tokyo) and Amyris (Emeryville, California) have begun the next phase of their plan to commercialize farnesene-derived fragrance molecules.
Having successfully completed feasibility testing, Takasago agreed to move forward with commercialization, starting with a first purchase for scale-up this quarter. They intend to introduce these aroma ingredients to the market in 2015.
“These new products will address customer demand resulting from the regulatory phase out of certain existing fragrance ingredients and will be some of the newest and most valuable fragrance ingredients on Takasago's palette,” said Masayuki Mita, senior vice president of the fragrance and aroma chemical division at Takasago.
Amyris and Takasago began their relationship in late 2012 by initiating feasibility studies to evaluate the opportunities of transforming farnesene into a range of fragrance ingredients.
